Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 30, 2024

SELL
$7.84 - $23.29 $82,539 - $245,197
-10,528 Closed
0 $0
Q1 2020

Aug 30, 2024

BUY
$5.57 - $11.5 $33,843 - $69,874
6,076 Added 136.48%
10,528 $89.5 Million
Q4 2019

Aug 30, 2024

BUY
$7.9 - $10.14 $35,170 - $45,143
4,452 New
4,452 $43.4 Million
Q3 2019

Aug 30, 2024

SELL
$9.17 - $12.01 $4,585 - $6,005
-500 Closed
0 $0
Q2 2019

Aug 30, 2024

BUY
$10.88 - $17.6 $5,440 - $8,800
500 New
500 $5.94 Million

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.